Apalutamide will decrease the extent or influence of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of apalutamide, a powerful CYP3A4 inducer, with medicine which might be CYP3A4 substrates may end up in reduced exposure to those medicines. On account of these changes https://cesara554dwo6.theideasblog.com/profile